Susana del Toro‐Arreola

Author

Also Known As

S Del Toro-Arreola, S del Toro-Arreola, S. Del Toro-Arreola, S. Del Toro‐Arreola, S. del Toro-Arreola, S.D. Toro-Arreola, SUSANA DEL TORO-ARREOLA, Susana Del Toro-Arreola, Susana Del Toro‑Arreola, Susana del Toro-Arreola

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Universidad de Guadalajara Mexican Social Security Institute Secretaría de Salud de Jalisco Hospital Civil de Guadalajara Universidad Nacional Autónoma de México

About

Susana del Toro‐Arreola is an author at Universidad de Guadalajara specializing in medicine, pathology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	444
2	Cell Biology	5	5	87
3	Health Sciences	2	2	104
4	Engineering	1	1	56
5	Cellular Physiology	1	1	21

Susana del Toro‐Arreola

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions Trinidad García‐Iglesias, Alicia Del Toro‐Arreola, Benibelks Albarran-Somoza, BMC Cancer	2009	210
Effect of d-limonene on immune response in BALB/c mice with lymphoma Susana del Toro‐Arreola, Edgardo Flores-Torales, Carlos Torres-Lozano, International Immunopharmacology InflammationAutoimmune DiseaseImmunotoxicologyMedicineImmune Regulation	2005	104
Escherichia/Shigella, SCFAs, and Metabolic Pathways—The Triad That Orchestrates Intestinal Dysbiosis in Patients with Decompensated Alcoholic Cirrhosis from Western Mexico Tonatiuh Abimael Baltazar-Díaz, Luz Alicia González-Hernández, J.M. Aldana-Ledesma, Microorganisms DysbiosisHost-microbe InteractionsGastroenterologyPathologyGut Microbiota	2022	84
Augmented serum level of major histocompatibility complex class I-related chain A (MICA) protein and reduced NKG2D expression on NK and T cells in patients with cervical cancer and precursor lesions Naela Arreygue-Garcia, Adrián Daneri‐Navarro, Alicia Del Toro‐Arreola, BMC Cancer	2008	83
Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features Zyanya Reyes-Castillo, Claudia Azucena Palafox‐Sánchez, Isela Parra‐Rojas, Clinical & Experimental Immunology	2015	58
Pentoxifylline sensitizes human cervical tumor cells to cisplatin-induced apoptosis by suppressing NF-kappa B and decreased cell senescence Georgina Hernández‐Flores, Pablo Cesar Ortiz‐Lazareno, José Manuel Lerma-Díaz, BMC Cancer	2011	57
Anti-fouling SERS-based immunosensor for point-of-care detection of the B7–H6 tumor biomarker in cervical cancer patient serum Sandeep Surendra Panikar, Nehla Banu, Jesse Haramati, Analytica Chimica Acta Biomarker (Medicine)OncologyCervical CancerAnti-fouling Sers-based ImmunosensorBiomedical Diagnostics	2020	56
Sensitization of cervix cancer cells to Adriamycin by Pentoxifylline induces an increase in apoptosis and decrease senescence Alejandro Bravo‐Cuéllar, Pablo Cesar Ortiz‐Lazareno, José Manuel Lerma-Díaz, Molecular Cancer	2010	38
High expression of prolactin receptor is associated with cell survival in cervical cancer cells Edgar Iván López-Pulido, José Francisco Muñóz-Valle, Susana del Toro‐Arreola, Cancer Cell International	2013	38
Urokinase-type plasminogen activator and plasminogen activator inhibitors (PAI-1 and PAI-2) in extracts of invasive cervical carcinoma and precursor lesions Adrián Daneri‐Navarro, Griselda Guadalupe Macías-López, Antonio Oceguera‐Villanueva, European Journal of Cancer OncologyCervical CancerInvasive Cervical CarcinomaMedicinePathology	1998	35

Page 1